NSE:MANIPALHOS

MANIPAL HEALTH ENTERPRI L

₹684.00
at close · 8 Oct 2026
▼ 16.00 (-2.29%)

Latest filings

  1. Compliance certificate for Q2 FY27 under SEBI Regulation 74(5) · Compliance
  2. AGM results: 10 of 11 resolutions passed; Upside Sharing with TPG rejected · Board & Shareholder Meetings
  3. 16th AGM: Revenue up 25% to Rs 10,336 cr, profit Rs 917 cr · Board & Shareholder Meetings
All filings ↓
Ask Nexa about MANIPAL HEALTH ENTERPRI L

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a multi-specialty hospital network across India, earning primarily from inpatient (IP) and outpatient (OP) services. Q1 FY27 revenue was INR 3,091 cr, with Centres of Excellence contributing about 65% of revenue and oncology alone at 12.2%. The network spans 49 hospitals with around 13,037 beds in 14 states; a 50th hospital (Electronic City, Bangalore, ~300 beds) was launched in July and Kinder Women's Hospital (~100 beds, Whitefield) was agreed to be acquired for INR 130 cr. Q1 FY27 IP volumes rose 39% and OP volumes 26%, with network occupancy at 65% (+290 bps) and average length of stay of 2.7 days; ARPOB excluding Sahyadri stood at INR 77,200 (+9%). The recently acquired Sahyadri chain added INR 332 cr of Q1 revenue at an ARPOB of INR 45,000. Digital services (e-pharmacy, telehealth, chatbot) generated INR 710 cr, roughly 23% of revenue, on 15,000 e-pharmacy orders, 17,000 telehealth consults and 9,600 chatbot interactions during the quarter. Network EBITDA was INR 749 cr at a 24.2% margin, with margins pressured by Sahyadri integration; reported net profit fell 4% on Rs 89 cr of post-tax interest on the Sahyadri acquisition debt, while adjusted PAT (excluding that interest) grew about 31% to INR 332 cr. FY27 capex is guided at ~INR 2,000 cr, with ~INR 900 cr already spent in Q1, and a 3-4 year envelope of ~INR 4,000 cr is planned to add ~3,000 beds; net debt/EBITDA is set to drop from 2.8x to 0.9x after IPO-proceed debt repayment.

Operating scale
Hospitals in network
49 hospitals (pre-Kinder), 51 post-acquisitionQ1 FY27
Bed capacity
~13,037 beds across 14 states (over 13,500 post-Kinder)Q1 FY27
Network occupancy
65% (+290 bps YoY)Q1 FY27
Average length of stay
2.7 daysQ1 FY27
ARPOB (ex-Sahyadri)
INR 77,200 (+8.7% YoY)Q1 FY27
FY27 capex guidance
~INR 2,000 cr (INR 900 cr spent in Q1); ~INR 4,000 cr over 3-4 years for ~3,000 bedsFY27 and beyond
Who pays it
Patients seeking inpatient and outpatient hospital care across 14 states, plus users of its e-pharmacy, telehealth and chatbot digital services.
Biggest cost
Sahyadri acquisition financing and integration spend weighed on Q1 margins; reported net profit fell 4% on Rs 89 cr of post-tax interest on acquisition debt and network EBITDA margin contracted to 24.2%.
Kind of business
Asset-heavy, capital-intensive hospital network with significant operating leverage on occupancy, ARPOB and case mix, currently digesting the Sahyadri acquisition and adding capacity.
Where it sits
Among India's largest multi-specialty hospital chains, with 49 hospitals and ~13,037 beds across 14 states at the time of its August 2026 listing.
Market Cap
₹82,583 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
—·
ROCE
ROE — · margin —
Leverage
—·
Debt / Equity · borrowings not filed

Scorecard

Measured from the filed financials — not investment advice

Not enough history to assess.

Charts

How has the market priced it — with filings on the timeline?

MANIPALHOS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from MANIPAL HEALTH ENTERPRI L's filed financials and exchange disclosures

What does MANIPAL HEALTH ENTERPRI L do?

MANIPAL HEALTH ENTERPRI L is listed on NSE and BSE, trading under the symbol MANIPALHOS.

Where can I track MANIPAL HEALTH ENTERPRI L's announcements?

Every NSE and BSE filing by MANIPAL HEALTH ENTERPRI L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.